RNA Therapeutics Core launches at Mass General Brigham to boost circular RNA research

The Mass General Brigham Gene and Cell Therapy Institute (GCTI) today announced it has launched the RNA Therapeutics Core, a first-of-its-kind, state-of-the-art facility and resource to advance the use of RNA technologies within and beyond the Mass General Brigham research ecosystem.

Medicare and Medicaid open coverage of anti-obesity drugs for heart patients

The Centers for Medicare and Medicaid Services said that anti-obesity drugs should be covered for patients getting them for additional medical conditions, a move that

March 22, 2024

RFK Jr. and Elon Musk want to ban pharma ads. They wouldn’t be the first to try

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

November 22, 2024

New Study Evaluates Virtual Reality to Reduce Scanxiety in Brain Tumor Patients

What You Should Know: AppliedVR, an immersive therapeutics (ITx) pioneer advancing a novel approach to medicine, today announced interim analysis results of a phase 2

July 21, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.